Lorraine Pelosof1, Chul Ahn1, Ang Gao1, Leora Horn1, Alejandra Madrigales1, Joan Cox1, Dauphne McGavic1, John D Minna1, Adi F Gazdar1, Joan Schiller1. 1. Affiliations of authors: Department of Internal Medicine, Hematology/Oncology, Harold C. Simmons Comprehensive Cancer Center (LP, AM, JDM, JS), Department of Biostatistics (CA, AG), Hamon Center for Therapeutic Oncology Research (JDM, AFG), Department of Pharmacology (JDM), Department of Pathology (AFG), UT Southwestern, Dallas, TX; Department of Hematology/Oncology, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Nashville, TN (LH, DM); Parkland Memorial Hospital, Dallas, TX (JC).
Abstract
Background: Approximately 10% to 15% of lung cancer cases in the United States occur in never smokers, but there has been much debate about whether this rate is increasing. To determine whether the proportion of never smokers among lung cancer cases is increasing, we conducted a retrospective study using registries from The University of Texas Southwestern Medical Center, Parkland Hospital, and Vanderbilt University. Methods: Registries were queried for demographic information from 1990 to 2013 including sex, age, stage, and self-reported smoking history. Ten thousand five hundred ninety-three non-small cell lung cancer (NSCLC) case patients and 1510 small cell lung cancer (SCLC) case patients were captured, and logistic regression analysis was performed. All statistical tests were two-sided. Results: The proportion of never-smoker NSCLC patients increased from 8.0% in the years 1990 to 1995 to 14.9% in 2011 to 2013 (P < .001). This increase was also observed using multivariable logistic regression after controlling for sex, stage at diagnosis, and race/ethnicity. The percentage of never smokers among SCLC case patients (1.5% in 1990-1995 to 2.5% in 2011-2013, P = .36) or squamous cell NSCLC case patients did not statistically significantly change during this period. Conclusions: This study demonstrates an increasing proportion of NSCLC patients who have never smoked in a large, diverse patient population between 1990 and 2013. Given that this increase appears independent of sex, stage, and race/ethnicity and also occurred in our county hospital, this trend is unlikely due to changes in referral patterns and suggests that the actual incidence of lung cancer in never smokers is increasing.
Background: Approximately 10% to 15% of lung cancer cases in the United States occur in never smokers, but there has been much debate about whether this rate is increasing. To determine whether the proportion of never smokers among lung cancer cases is increasing, we conducted a retrospective study using registries from The University of Texas Southwestern Medical Center, Parkland Hospital, and Vanderbilt University. Methods: Registries were queried for demographic information from 1990 to 2013 including sex, age, stage, and self-reported smoking history. Ten thousand five hundred ninety-three non-small cell lung cancer (NSCLC) case patients and 1510 small cell lung cancer (SCLC) case patients were captured, and logistic regression analysis was performed. All statistical tests were two-sided. Results: The proportion of never-smoker NSCLCpatients increased from 8.0% in the years 1990 to 1995 to 14.9% in 2011 to 2013 (P < .001). This increase was also observed using multivariable logistic regression after controlling for sex, stage at diagnosis, and race/ethnicity. The percentage of never smokers among SCLC case patients (1.5% in 1990-1995 to 2.5% in 2011-2013, P = .36) or squamous cell NSCLC case patients did not statistically significantly change during this period. Conclusions: This study demonstrates an increasing proportion of NSCLCpatients who have never smoked in a large, diverse patient population between 1990 and 2013. Given that this increase appears independent of sex, stage, and race/ethnicity and also occurred in our county hospital, this trend is unlikely due to changes in referral patterns and suggests that the actual incidence of lung cancer in never smokers is increasing.
Authors: Wei Zhang; Elizabeth B McQuitty; Randall Olsen; Hongxin Fan; Heather Hendrickson; Fermin O Tio; Keith Newton; Philip T Cagle; Jaishree Jagirdar Journal: Arch Pathol Lab Med Date: 2013-08-12 Impact factor: 5.534
Authors: Kelsie L Thu; Emily A Vucic; Raj Chari; Wei Zhang; William W Lockwood; John C English; Rong Fu; Pei Wang; Ziding Feng; Calum E MacAulay; Adi F Gazdar; Stephen Lam; Wan L Lam Journal: PLoS One Date: 2012-03-07 Impact factor: 3.240
Authors: Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Peter J Campbell; Michael R Stratton Journal: Cell Rep Date: 2013-01-10 Impact factor: 9.423
Authors: Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton Journal: Nature Date: 2013-08-14 Impact factor: 49.962
Authors: Michael J Thun; Lindsay M Hannan; Lucile L Adams-Campbell; Paolo Boffetta; Julie E Buring; Diane Feskanich; W Dana Flanders; Sun Ha Jee; Kota Katanoda; Laurence N Kolonel; I-Min Lee; Tomomi Marugame; Julie R Palmer; Elio Riboli; Tomotaka Sobue; Erika Avila-Tang; Lynne R Wilkens; Jon M Samet Journal: PLoS Med Date: 2008-09-09 Impact factor: 11.069
Authors: H Dean Hosgood; Wei Hu; Nathaniel Rothman; Madelyn Klugman; Stephanie J Weinstein; Jarmo R Virtamo; Demetrius Albanes; Richard Cawthon; Qing Lan Journal: Carcinogenesis Date: 2019-08-22 Impact factor: 4.944
Authors: Karen L Reckamp; Carolyn E Behrendt; Thomas P Slavin; Stacy W Gray; Danielle K Castillo; Marianna Koczywas; Mihaela C Cristea; Kirsten M Babski; Donna Stearns; Catherine A Marcum; Yenni P Rodriguez; Amie J Hass; Mary M Vecchio; Pamela Mora; Aleck E Cervantes; Sharon R Sand; Rosa M Mejia; Terrence C Tsou; Ravi Salgia; Jeffrey N Weitzel Journal: Cancer Date: 2021-04-15 Impact factor: 6.921
Authors: Mindy C DeRouen; Alison J Canchola; Caroline A Thompson; Anqi Jin; Sixiang Nie; Carmen Wong; Daphne Lichtensztajn; Laura Allen; Manali I Patel; Yihe G Daida; Harold S Luft; Salma Shariff-Marco; Peggy Reynolds; Heather A Wakelee; Su-Ying Liang; Beth E Waitzfelder; Iona Cheng; Scarlett L Gomez Journal: J Natl Cancer Inst Date: 2022-01-11 Impact factor: 11.816